Project Details
Description
Amplification of oncogene MYCN is a hallmark of neuroblastoma, and is associated with metastasis and very poor survival. However, despite the identification of MYCN-amplification as an adverse prognostic marker, no drugs that target MYCN have been developed.
| Status | Active |
|---|---|
| Effective start/end date | 1/1/13 → … |
Funding
- Alex's Lemonade Stand Foundation for Childhood Cancer: US$250,000.00
ASJC Scopus Subject Areas
- Cancer Research
- Oncology
- Biochemistry, Genetics and Molecular Biology(all)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.